Efficacy of Virologically Suppressed Adults With HIV Switching From B/F/TAF to Dolutegravir/3TC
OCT 23, 2023
Description Community
About
In this podcast, Charlotte M. Rolle, MD, MPH, discusses her team's research that evaluated the efficacy and safety of switching HIV treatment using bictegravir/emtricitabine/tenofovir alafenamide to dolutegravir/lamivudine. Dr Rolle spoke about this topic during her poster presentation at IDWeek 2023 in Boston, Massachusetts.
Comments